VRTX
STRONGVERTEX PHARMACEUTICALS INC / MA
CIK: 0000875320
Last activity: 3 days ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (7 total, 7 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| LEIDEN JEFFREY M Executive Chairman | 0 | 12 | -$28.65M | 36,456 shares $16.49M |
| WAGNER CHARLES F JR EVP, CO & FO | 0 | 3 | -$10.78M | 37,725 shares $17.39M |
| Tatsis Ourania EVP, Chief Reg. & Quality Off. | 0 | 3 | -$4.38M | 51,436 shares $23.68M |
| Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 0 | 2 | -$1.89M | 22,046 shares $10.15M |
| Biller Jonathan EVP and Chief Legal Officer | 0 | 2 | -$1.04M | 20,819 shares $9.59M |
| Bunnage Mark E. EVP, Chief Scientific Officer | 0 | 1 | -$931K | 12,914 shares $5.95M |
| Ambrose Kristen SVP & Chief Accounting Officer | 0 | 1 | -$634K | 10,127 shares $4.66M |
Recent Transactions
2,021 shares @ $460.43
$931K
Feb 11, 2026
1,925 shares @ $460.43
$886K
Feb 11, 2026
1,751 shares @ $460.43
$806K
Feb 11, 2026
1,376 shares @ $460.43
$634K
Feb 11, 2026
466 shares @ $460.43
$215K
Feb 11, 2026
4,500 shares @ $474.99
$2.14M
Jan 7, 2026
9,532 shares @ $461.00
$4.39M
Jan 6, 2026
15,681 shares @ $452.20
$7.09M
Dec 3, 2025
10,360 shares @ $453.34
$4.70M
Dec 3, 2025
7,899 shares @ $445.56
$3.52M
Dec 3, 2025
7,000 shares @ $461.00
$3.23M
Dec 3, 2025
7,000 shares @ $451.00
$3.16M
Dec 3, 2025
5,880 shares @ $449.84
$2.65M
Dec 3, 2025
5,809 shares @ $451.20
$2.62M
Dec 3, 2025
4,500 shares @ $449.99
$2.02M
Dec 3, 2025
4,469 shares @ $440.40
$1.97M
Dec 3, 2025
4,352 shares @ $444.36
$1.93M
Dec 3, 2025
2,469 shares @ $443.21
$1.09M
Dec 3, 2025
2,320 shares @ $448.78
$1.04M
Dec 3, 2025
2,070 shares @ $455.22
$942K
Dec 3, 2025
1,320 shares @ $441.26
$582K
Dec 3, 2025
1,152 shares @ $447.05
$515K
Dec 3, 2025
347 shares @ $449.00
$156K
Dec 3, 2025
2,500 shares @ $434.58
$1.09M
Nov 17, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.